Tullia C. Bruno

12.0k total citations · 11 hit papers
91 papers, 7.3k citations indexed

About

Tullia C. Bruno is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tullia C. Bruno has authored 91 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 62 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tullia C. Bruno's work include Cancer Immunotherapy and Biomarkers (54 papers), Immune Cell Function and Interaction (36 papers) and Immunotherapy and Immune Responses (28 papers). Tullia C. Bruno is often cited by papers focused on Cancer Immunotherapy and Biomarkers (54 papers), Immune Cell Function and Interaction (36 papers) and Immunotherapy and Immune Responses (28 papers). Tullia C. Bruno collaborates with scholars based in United States, Taiwan and China. Tullia C. Bruno's co-authors include Dario A.A. Vignali, Charles G. Drake, Creg J. Workman, Drew M. Pardoll, Derese Getnet, Robert L. Ferris, Joseph F. Grosso, Monica V. Goldberg, Anthony R. Cillo and Edward L. Hipkiss and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Tullia C. Bruno

83 papers receiving 7.2k citations

Hit Papers

Evidence for a Role of the PD-1:PD-L1 Pathway in Immune R... 2013 2026 2017 2021 2013 2020 2017 2019 2021 200 400 600

Peers

Tullia C. Bruno
Seth B. Coffelt United Kingdom
Terri McClanahan United States
G. Kenneth Haines United States
Allen T. Bruce United States
Stephen L. Shiao United States
Yuanyuan Zha United States
Seth B. Coffelt United Kingdom
Tullia C. Bruno
Citations per year, relative to Tullia C. Bruno Tullia C. Bruno (= 1×) peers Seth B. Coffelt

Countries citing papers authored by Tullia C. Bruno

Since Specialization
Citations

This map shows the geographic impact of Tullia C. Bruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tullia C. Bruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tullia C. Bruno more than expected).

Fields of papers citing papers by Tullia C. Bruno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tullia C. Bruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tullia C. Bruno. The network helps show where Tullia C. Bruno may publish in the future.

Co-authorship network of co-authors of Tullia C. Bruno

This figure shows the co-authorship network connecting the top 25 collaborators of Tullia C. Bruno. A scholar is included among the top collaborators of Tullia C. Bruno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tullia C. Bruno. Tullia C. Bruno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández-Verdín, Isaias, et al.. (2026). Tertiary lymphoid structures in the era of cancer therapy. Journal of Experimental & Clinical Cancer Research. 45(1). 48–48.
2.
Ruffin, Ayana T., Sheryl Kunning, Anjali Rohatgi, et al.. (2025). Dysfunctional CD11c CD21 extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer. Science Translational Medicine. 17(786). eadh1315–eadh1315. 4 indexed citations
3.
Bailey, Nathanael G., Sheryl Kunning, Cynthia S. Hinck, et al.. (2025). TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma. Cancer Research Communications. 5(8). 1441–1457.
4.
Kunning, Sheryl, Huda I. Atiya, Ayana T. Ruffin, et al.. (2024). The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell. 42(11). 1864–1881.e5. 24 indexed citations
5.
Ma, Xiaojun, Elena S. Kim, Michael J. Becich, et al.. (2024). Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments. Cancer Research Communications. 4(8). 2133–2146. 4 indexed citations
6.
Emens, Leisha A., Pedro Romero, Ana C. Anderson, et al.. (2024). Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for ImmunoTherapy of Cancer. 12(6). e009063–e009063. 64 indexed citations breakdown →
7.
Chen, Fangyuan, Sayali Onkar, Jian Zou, et al.. (2024). Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer. npj Precision Oncology. 8(1). 257–257. 1 indexed citations
8.
Shan, Feng, Anthony R. Cillo, Carly Cardello, et al.. (2023). Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells. Science Immunology. 8(87). eadf6717–eadf6717. 16 indexed citations
10.
Özer, Muhammet, Charan Thej Reddy Vegivinti, Jennifer Holder‐Murray, et al.. (2023). Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm. Cancers. 15(15). 3833–3833. 13 indexed citations
11.
Somasundaram, Ashwin, Anthony R. Cillo, Caleb Lampenfeld, et al.. (2022). Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells. Cancer Immunology Research. 10(7). 885–899. 18 indexed citations
12.
Cillo, Anthony R., Nathanael G. Bailey, Sayali Onkar, et al.. (2022). Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks. Clinical Cancer Research. 28(22). 4968–4982. 51 indexed citations
13.
Rahman, Syed A., Anthony R. Cillo, Ashwin Somasundaram, et al.. (2022). Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19. Cell Reports. 39(13). 111020–111020. 12 indexed citations
14.
Onkar, Sayali, Neil Carleton, Peter C. Lucas, et al.. (2022). The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes. Cancer Discovery. 13(1). 23–40. 133 indexed citations
15.
Cascio, Sandra, Chelsea Chandler, Bingsi Gao, et al.. (2021). Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition. Science Advances. 7(46). eabi5790–eabi5790. 54 indexed citations
16.
Andrews, Lawrence P., Ashwin Somasundaram, Jessica Moskovitz, et al.. (2020). Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding. Science Immunology. 5(49). 59 indexed citations
17.
Greene, Lisa I., Tullia C. Bruno, Jessica L. Christenson, et al.. (2018). A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma. Molecular Cancer Research. 17(1). 131–139. 103 indexed citations
18.
Simons, Brian W., Nicholas M. Durham, Tullia C. Bruno, et al.. (2014). A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. The Journal of Pathology. 235(3). 478–489. 65 indexed citations
19.
Lyford-Pike, Sofía, Shiwen Peng, Geoffrey D. Young, et al.. (2013). Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma. Cancer Research. 73(6). 1733–1741. 602 indexed citations breakdown →
20.
Yen, Hung‐Rong, Timothy Harris, Satoshi Wada, et al.. (2009). Tc17 CD8 T Cells: Functional Plasticity and Subset Diversity. The Journal of Immunology. 183(11). 7161–7168. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026